Speech-Language Pathologists in Lincoln, RI Accepting Medicare

11 Speech-Language Pathologists found. Showing 1 - 11

Rebecca Hermann Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 50 Woodland St, Lincoln, RI 02865 Phone: 401-723-5240

Patricia Ryan Martin Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1992 Old Louisquisset Pike, Lincoln, RI 02865 Phone: 401-475-0653    Fax: 401-475-0729

Kathryn Mary Calle, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1992 Old Louisquisset Pike, Lincoln, RI 02865 Phone: 401-475-0653

Michelle Robert Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9 Sables Way, Lincoln, RI 02865 Phone: 401-578-3315

Laurie Jean Mckinnon, M.S CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25 Linda St, Lincoln, RI 02865 Phone: 401-305-6787

Mrs. Rachael Ryder, MS CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3 Sheffield Dr, Lincoln, RI 02865 Phone: 401-724-1487

Miss Rebecca Gallucci, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6 Blackstone Valley Pl, Suite 109, Lincoln, RI 02865 Phone: 401-529-4369

Robi-lyn Beaudry, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 237 Front St, Lincoln, RI 02865 Phone: 401-475-0653

Cassandra M Dodd Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6 Blackstone Valley Pl Ste 306a, Lincoln, RI 02865 Phone: 401-443-5252

Mrs. Nancy A Gage, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6 Blackstone Valley Pl, Suite 109, Lincoln, RI 02865 Phone: 401-438-2730

Miss Sherry Ann Lusiak, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 Great Rd, Lincoln, RI 02865 Phone: 401-475-6367    Fax: 401-475-6367

News Archive

Scientists identify new therapeutic targets to inhibit progression of Alzheimer's disease

To stop the progression of Alzheimer's disease in the early stage, it is necessary to identify new therapeutic targets. Prof. Yunpeng Cao and team from the First Affiliated Hospital of China Medical University examined striatal-enriched phosphatase 61 expression in the brain tissues of Alzheimer's disease rats using in vivo and in vitro models, and analyzed the molecular mechanism by which striatal-enriched phosphatase 61 regulates N-methyl-D- aspartate receptor 2B transport.

Curis announces inclusion in NASDAQ Biotechnology Index

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (NBI), which will become effective prior to market open on Monday, May 24, 2010.

ViiV Healthcare presents positive results from LATTE-2 study at CROI

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive results from the LATTE-2 study at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Headline results were announced in November 2015.

KHN's ‘What the Health?': What would Dr. Fauci do?

Since the mid-1980s, whenever there's been a public health crisis, America — and six U.S. presidents — have turned to Dr. Anthony Fauci.

Pharma enhances its focus on Asia-Pacific partnerships

While the Japanese market still dominates deal activities in the Asia-Pacific (APAC) region, companies and research institutes in emerging APAC countries have recently been attracting high calibre collaborators, according to the latest analysis by Datamonitor.

Read more Medical News

› Verified 5 days ago